Effect of 3,4-diaminopyridine on rat extensor digitorum longus muscle paralyzed by local injection of botulinum neurotoxin

被引:33
作者
Adler, M [1 ]
Macdonald, DA [1 ]
Sellin, LC [1 ]
Parker, GW [1 ]
机构
[1] USA,MED RES INST INFECT DIS,DIV TOXINOL,FREDERICK,MD 21701
关键词
D O I
10.1016/0041-0101(95)00127-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The actions of the K+ channel blocker, 3,4-diaminopyridine (3,4-DAP), were studied in the rat extensor digitorum longus (EDL) muscle following local inhibition of neuromuscular transmission by botulinum neurotoxin (BoNT). Local paralysis of the EDL muscle was induced by s.c. injections of BoNT serotypes A, B, E or F over the anterior tibialis muscle, One to 14 days later, the rats were anesthetized with urethane, and isometric twitch tensions following stimulation of the peroneal nerve were measured in situ. Muscles were paralyzed within 24 hr of administration of 5 mouse LD(50) units (U) of BoNT/A and remained inhibited for the entire 14-day period of observation. Similar levels of inhibition, but of shorter duration, were observed after local injection of 20 U of BoNT/E, 10(4) U of BoNT/B or 20 U of BoNT/F. 3,4-DAP (4 mg/kg, i.v.) potentiated twitch tensions markedly in BoNT/A intoxicated muscle. The increase in tension developed rapidly (halftime = 5.81 +/- 0.6 min), persisted for approximately 1 hr, then decayed slowly with a halftime of 25.2 +/- 4.6 min. Subsequent administration of 3,4-DAP restored tensions to the original maxima, and this procedure could be repeated up to eight times with no decrement. The action of 3,4-DAP was comparable when given 1, 2, 3 or 7 days after BoNT/A and enhanced when administered 14 days after toxin injection. 3,4-DAP was less effective in reversing BoNT/E-induced muscle paralysis and nearly ineffective in antagonizing the paralytic actions of BoNT/B or BoNT/F. The results indicate that 3,4-DAP is of benefit in BoNT/A and BoNT/E intoxication, but is of marginal value after exposure to serotypes B and F.
引用
收藏
页码:237 / 249
页数:13
相关论文
共 39 条
  • [1] EFFECTS OF SUBACUTE PYRIDOSTIGMINE ADMINISTRATION ON MAMMALIAN SKELETAL-MUSCLE FUNCTION
    ADLER, M
    DESHPANDE, SS
    FOSTER, RE
    MAXWELL, DM
    ALBUQUERQUE, EX
    [J]. JOURNAL OF APPLIED TOXICOLOGY, 1992, 12 (01) : 25 - 33
  • [2] ANTAGONISM OF BOTULINUM TOXIN-INDUCED MUSCLE WEAKNESS BY 3,4-DIAMINOPYRIDINE IN RAT PHRENIC NERVE-HEMIDIAPHRAGM PREPARATIONS
    ADLER, M
    SCOVILL, J
    PARKER, G
    LEBEDA, FJ
    PIOTROWSKI, J
    DESHPANDE, SS
    [J]. TOXICON, 1995, 33 (04) : 527 - 537
  • [3] Adler M., 1994, THERAPY BOTULINUM TO, P63
  • [4] BALL AP, 1979, Q J MED, V191, P473
  • [5] BENETT MK, 1993, P NATL ACAD SCI USA, V90, P2559
  • [6] PRELIMINARY TRIAL OF 3,4-DIAMINOPYRIDINE IN PATIENTS WITH MULTIPLE-SCLEROSIS
    BEVER, CT
    LESLIE, J
    CAMENGA, DL
    PANITCH, HS
    JOHNSON, KP
    [J]. ANNALS OF NEUROLOGY, 1990, 27 (04) : 421 - 427
  • [7] BINZ T, 1994, J BIOL CHEM, V269, P1617
  • [8] BOTULINUM NEUROTOXIN-A SELECTIVELY CLEAVES THE SYNAPTIC PROTEIN SNAP-25
    BLASI, J
    CHAPMAN, ER
    LINK, E
    BINZ, T
    YAMASAKI, S
    DECAMILLI, P
    SUDHOF, TC
    NIEMANN, H
    JAHN, R
    [J]. NATURE, 1993, 365 (6442) : 160 - 163
  • [9] BURGEN ASV, 1949, J PHYSIOL-LONDON, V134, P264
  • [10] CARPENTE.FG, 1967, J PHYSIOL-LONDON, V188, P1